Rekate Harold L, Kranz Dory
Barrow Neurologic Institute, University of Arizona, College of Medicine, Phoenix, AZ 85013, USA.
Semin Pediatr Neurol. 2009 Mar;16(1):27-30. doi: 10.1016/j.spen.2009.01.001.
Headache is one of the most common afflictions suffered by humans. Headache in patients with a shunt triggers a series of events that includes utilization of expensive technologies and often potentially dangerous surgical intervention. The purpose of this study was to determine the incidence of headaches in patients with shunts and, hopefully, the relationship of those headache disorders to the treatment of hydrocephalus. The Hydrocephalus Association maintains a self-reporting database recorded from individuals treated for hydrocephalus and their families. This database was mined to determine the incidence of severe headaches requiring treatment and interfering with normal life in patients who have been treated for hydrocephalus. There were 1,242 responders between the ages of 19 months and 45 years of age. Of these, 1,233 answered the question, "Do you or your family member suffer from (does your child complain of) frequent or chronic headaches?" This subset forms the basis of this study. Three groups were defined by age: children (19 months-12 years), adolescents (13 years-19 years), and young adults (20 years-45 years). Most respondents were initially treated during infancy (before 18 months of age); 84% of children and 69% of both adolescents and young adults were treated very early in life. Severe headaches became a more frequent problem as the age of the population treated for hydrocephalus increased. In terms of frequency and severity of headaches, direct comparisons with epidemiologic studies of normal populations are difficult because of the limitations of data available in the database. However, it is likely that this population has a higher incidence of severe headaches than normal populations. The cost of management of headaches in this population is very high, and the patients are at risk throughout life. Early treatment decisions have a significant effect on later quality of life. Strategies that lead to normalization of cerebrospinal fluid dynamics and life without shunt dependency are justified if they can be shown to improve later quality of life.
头痛是人类最常见的病痛之一。患有分流器的患者出现头痛会引发一系列事件,包括使用昂贵的技术,且往往需要进行有潜在危险的手术干预。本研究的目的是确定分流器患者头痛的发生率,并希望确定这些头痛病症与脑积水治疗之间的关系。脑积水协会维护着一个由接受脑积水治疗的个人及其家属进行自我报告的数据库。对该数据库进行挖掘,以确定在接受脑积水治疗的患者中,需要治疗且干扰正常生活的严重头痛的发生率。有1242名年龄在19个月至45岁之间的应答者。其中,1233人回答了“您或您的家庭成员(您的孩子是否抱怨)经常或慢性头痛?”这个问题。这一子集构成了本研究的基础。根据年龄分为三组:儿童(19个月至12岁)、青少年(13岁至19岁)和青年成人(20岁至45岁)。大多数应答者最初是在婴儿期(18个月之前)接受治疗;84%的儿童以及69%的青少年和青年成人在生命早期就接受了治疗。随着接受脑积水治疗人群年龄的增加,严重头痛成为了一个更频繁出现的问题。就头痛的频率和严重程度而言,由于数据库中可用数据的局限性,很难与正常人群的流行病学研究进行直接比较。然而,这一人群中严重头痛的发生率可能高于正常人群。这一人群中头痛管理的成本非常高,而且患者一生都面临风险。早期的治疗决策对后期的生活质量有重大影响。如果能够证明可以改善后期生活质量,那么能够使脑脊液动力学正常化且无需依赖分流器的生活的策略是合理的。